Hualan Biological Engineering
002007.SZ
#3019
Rank
S$5.66 B
Marketcap
$3.10
Share price
-4.08%
Change (1 day)
-28.94%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Operating Margin for Hualan Biological Engineering (002007.SZ)

Operating Margin as of November 2024 (TTM): 35.08%

According to Hualan Biological Engineering's latest financial reports and stock price the company's current Operating Margin is 35.08%. At the end of 2022 the company had an Operating Margin of 31.62%.

Operating Margin history for Hualan Biological Engineering from 2004 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202231.62%-16.91%
202138.06%-10.98%
202042.75%-1.77%
201943.52%0.73%
201843.20%10.79%
201739.00%-16.56%
201646.74%-0.68%
201547.05%-6.8%
201450.49%0.57%
201350.20%30.88%
201238.36%-19.84%
201147.85%-26.26%
201064.89%1.15%
200964.15%40.09%
200845.80%25.43%
200736.51%42.77%
200625.57%55.24%
200516.47%17.7%
200414.00%-15.23%
200316.51%-15.49%
200219.54%34.62%
200114.51%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.